Surrozen, Inc./DE — Form D
Surrozen, Inc./DE of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-04-08. The offering totals $175.0M, of which $76.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-04-08
- Form: D
- Accession: 0001824893-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $175.0M
- Amount sold: $76.4M
- Remaining: $98.6M
- Investors: 29
- Date of first sale: 2025-03-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-543181
Issuer
- Name: Surrozen, Inc./DE
- CIK: 0001824893
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 650-489-9000
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Anna J Berkenblit, M.D. | Director | South San Francisco, CA |
| Eric J Bjerkholt | Director | South San Francisco, CA |
| Christopher J Chai | Director | South San Francisco, CA |
| Mary J Haak-Frendscho, Ph.D. | Director | South San Francisco, CA |
| Tim J Kutzkey, Ph.D. | Director | South San Francisco, CA |
| Shao-Lee J Lin, M.D., Ph.D. | Director | South San Francisco, CA |
| Craig Parker | Director | Aurora, CO |
| Mace J Rothenberg, M.D. | Director | South San Francisco, CA |
| David J Woodhouse, Ph.D. | Director | South San Francisco, CA |
| Yang J Li, Ph.D. | Executive Officer | South San Francisco, CA |
| Craig Parker | Executive Officer | Aurora, CO |
| Charles Williams | Executive Officer | Allen, TX |
Other filings by this issuer (1)
More